Israel
· Delayed Price · Currency is ILS · Price in ILA Ilex Medical Statistics
Total Valuation
Ilex Medical has a market cap or net worth of ILS 682.36 million. The enterprise value is 509.19 million.
| Market Cap | 682.36M |
| Enterprise Value | 509.19M |
Important Dates
The next estimated earnings date is Sunday, August 24, 2025.
| Earnings Date | Aug 24, 2025 |
| Ex-Dividend Date | Apr 7, 2025 |
Share Statistics
Ilex Medical has 11.19 million shares outstanding. The number of shares has increased by 0.25% in one year.
| Current Share Class | 11.19M |
| Shares Outstanding | 11.19M |
| Shares Change (YoY) | +0.25% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 62.77% |
| Owned by Institutions (%) | 12.84% |
| Float | 2.85M |
Valuation Ratios
The trailing PE ratio is 17.41.
| PE Ratio | 17.41 |
| Forward PE | n/a |
| PS Ratio | 0.74 |
| PB Ratio | 1.06 |
| P/TBV Ratio | 1.09 |
| P/FCF Ratio | 20.38 |
| P/OCF Ratio | 11.56 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 5.15, with an EV/FCF ratio of 15.21.
| EV / Earnings | 14.90 |
| EV / Sales | 0.55 |
| EV / EBITDA | 5.15 |
| EV / EBIT | 9.91 |
| EV / FCF | 15.21 |
Financial Position
The company has a current ratio of 2.60, with a Debt / Equity ratio of 0.08.
| Current Ratio | 2.60 |
| Quick Ratio | 1.86 |
| Debt / Equity | 0.08 |
| Debt / EBITDA | 0.46 |
| Debt / FCF | 1.47 |
| Interest Coverage | 24.38 |
Financial Efficiency
Return on equity (ROE) is 6.20% and return on invested capital (ROIC) is 5.42%.
| Return on Equity (ROE) | 6.20% |
| Return on Assets (ROA) | 3.73% |
| Return on Invested Capital (ROIC) | 5.42% |
| Return on Capital Employed (ROCE) | 8.26% |
| Revenue Per Employee | 5.18M |
| Profits Per Employee | 191,966 |
| Employee Count | 178 |
| Asset Turnover | 0.93 |
| Inventory Turnover | 4.44 |
Taxes
In the past 12 months, Ilex Medical has paid 15.48 million in taxes.
| Income Tax | 15.48M |
| Effective Tax Rate | 28.26% |
Stock Price Statistics
The stock price has increased by +3.64% in the last 52 weeks. The beta is 0.05, so Ilex Medical's price volatility has been lower than the market average.
| Beta (5Y) | 0.05 |
| 52-Week Price Change | +3.64% |
| 50-Day Moving Average | 6,184.66 |
| 200-Day Moving Average | 6,830.13 |
| Relative Strength Index (RSI) | 62.02 |
| Average Volume (20 Days) | 4,044 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Ilex Medical had revenue of ILS 922.08 million and earned 34.17 million in profits. Earnings per share was 3.05.
| Revenue | 922.08M |
| Gross Profit | 215.11M |
| Operating Income | 59.35M |
| Pretax Income | 54.76M |
| Net Income | 34.17M |
| EBITDA | 93.07M |
| EBIT | 59.35M |
| Earnings Per Share (EPS) | 3.05 |
Balance Sheet
The company has 222.51 million in cash and 49.33 million in debt, giving a net cash position of 173.18 million or 15.48 per share.
| Cash & Cash Equivalents | 222.51M |
| Total Debt | 49.33M |
| Net Cash | 173.18M |
| Net Cash Per Share | 15.48 |
| Equity (Book Value) | 646.41M |
| Book Value Per Share | 57.47 |
| Working Capital | 428.62M |
Cash Flow
In the last 12 months, operating cash flow was 59.04 million and capital expenditures -25.56 million, giving a free cash flow of 33.48 million.
| Operating Cash Flow | 59.04M |
| Capital Expenditures | -25.56M |
| Free Cash Flow | 33.48M |
| FCF Per Share | 2.99 |
Margins
Gross margin is 23.33%, with operating and profit margins of 6.44% and 3.71%.
| Gross Margin | 23.33% |
| Operating Margin | 6.44% |
| Pretax Margin | 5.94% |
| Profit Margin | 3.71% |
| EBITDA Margin | 10.09% |
| EBIT Margin | 6.44% |
| FCF Margin | 3.63% |
Dividends & Yields
This stock pays an annual dividend of 1.22, which amounts to a dividend yield of 1.97%.
| Dividend Per Share | 1.22 |
| Dividend Yield | 1.97% |
| Dividend Growth (YoY) | -10.63% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 44.68% |
| Buyback Yield | -0.25% |
| Shareholder Yield | 1.63% |
| Earnings Yield | 5.01% |
| FCF Yield | 4.91% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on August 21, 2000. It was a forward split with a ratio of 9.
| Last Split Date | Aug 21, 2000 |
| Split Type | Forward |
| Split Ratio | 9 |
Scores
Ilex Medical has an Altman Z-Score of 3.81 and a Piotroski F-Score of 5.
| Altman Z-Score | 3.81 |
| Piotroski F-Score | 5 |